Viral mismatch between circulating strains and vaccine may have weighed down effectiveness ...

CLEVELAND — The FDA has reversed course and announced it will now review Moderna's mRNA flu vaccine application after initially declining to accept it earlier this month. The agency had raised ...

The FDA will now review Moderna’s seasonal mRNA influenza vaccine application, setting a mid-2026 decision date. In a regulatory turnaround, the FDA will now review Moderna’s seasonal mRNA flu vaccine ...

CSL Seqirus has been awarded a new contract agreement to support the influenza pandemic preparedness plans of the Canadian government’s Public Health Agency of ...

Company Initiates Regulatory Discussions with CDSCO; Plans 408-Patient Pivotal Study Targeting Standard-Risk Several Viral Infected Outpatients ...

FDA advisers recommend fall flu shot changes to include the new subclade K H3N2 variant for the 2026-27 season, improving vaccine relevance.

The Marblehead Board of Health is urging residents to review their vaccination histories following two recent measles cases reported in Massachusetts and continued seasonal respiratory illness ...

Company Initiates Regulatory Discussions with CDSCO; Plans 408-Patient Pivotal Study Targeting Standard-Risk Several Viral Infected Outpatients BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Bioxytran, ...

B.C.’s provincial health officer says respiratory illness season is over with recent data showing a decline in illnesses.